Validation of COPD associated gene profile and impact of budesonide/formoterol inhaled therapy to alter this profile.
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2015
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Therapeutic Use
- 19 Dec 2015 New trial record